Sino Biopharmaceutical LtdSino Biopharmaceutical Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The report of Sino Biopharmaceutical Ltd is assembled by All Street Sevva using advanced Cognitive Robots. This webpage includes a questions and answers section for Sino Biopharmaceutical Ltd. Other corporations in the rating peer group for Sino Biopharmaceutical Ltd are shown.

Sino Biopharmaceutical Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 6.0, social score of 7.0 and governance score of 5.7.

SDG Transparency Score for Sino Biopharmaceutical Ltd 
Low
0 - 3

6.2

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Sino Biopharmaceutical Ltd 
6.0

Environmental

7.0

Social

5.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
427Scancell Holdings PLC
6.3
High
427Verastem Inc
6.3
High
450Sino Biopharmaceutical Ltd
6.2
High
450Cannasouth Ltd
6.2
High
450CareDx International AB
6.2
High
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Sino Biopharmaceutical Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd offer flexible work?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose water use targets?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Sino Biopharmaceutical Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Sino Biopharmaceutical Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Sino Biopharmaceutical Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Sino Biopharmaceutical Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Sino Biopharmaceutical Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Sino Biopharmaceutical Ltd
These potential risks are based on the size, segment and geographies of the company.

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company's products include oncology medicines comprising Qingkeshu tablets, Anxian capsules, Yinishu tablets, Genike capsules, Anyue capsules, and Leweixin injections; cardio-cerebral vascular medicines, including Kaina and Anrixin tablets; hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; orthopedic medicines consisting of Gaisanchun capsules, Yigu injections, and Taiyan tablets; respiratory system medicines; parenteral nutritious medicines comprising Xinhaineng and Fenghaina injections; and other medicines, including Tuotuo tablets, Debaian cataplasms, and Qingliming injections. It also offers Aprepitant capsules, Lenvatinib Mesilate capsules, Vortioxetine Hydrobromide tablets, Edaravone injection, Amlodipine Besylate and Atorvastatin Calcium tablets, Sofosbuvir tablets, Sitagliptin Phosphate tablets, Colistimethate Sodium for injection, and Tofacitinib Citrate tablets. In addition, the company holds properties; retails and distributes pharmaceutical products; offers optometry for optical glasses and sells ophthalmic products; operates hospitals; provides medical management and health information consultancy, as well as bio-tech transfer and consultation services; manufactures and sells health food; and offers orthopedic outpatient and surgical procedures. Further, it manufactures, sells, and distributes health food; develops medical and health technology; trades in optical glasses; and researches, develops, and sells medical devices and active pharmaceutical ingredients. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

Sorry!

Failed to process!